|
Prof. Dr. Olga Golubnitschaja
• President of European Association for Predictive, Preventive & Personalised Medicine (EPMA, epmanet.eu) and its founding member
• Head of the world's first department for 3P medicine (at Rheinische Friedrich-Wilhelms-Universität Bonn)
• Editor-in-Chief of the EPMA Journal, SpringerNature (IF 8.836, CiteScore 11.3), springer.com/journal/13167
• Editor-in-Chief of the book series “Advances in Predictive, Preventive and Personalised Medicine”, SpringerNature, springer.com/series/10051
• Author of more than 400 international publications (research and review articles, position papers, books, book and congress contributions) in the innovative field of 3P medicine with research focus on: suboptimal health conditions, pre- and perinatal diagnostics, diagnostics of stress-related diseases, diagnostics of cardiovascular diseases and neurodegenerative diseases, predictive diagnostics in cancer and diabetes
• Vice-Chair in the “Marie Curie” programme at European Commission in Brussels. In 2010-2013, she was involved in creating the 3P medicine-related contents of the European programme “Horizon 2020”.
• Education in journalism, biotechnology and medicine
• Several international awards in biomedical research
|
 Dr. Vincenzo Costigliola
• Graduate in Medicine from the University of Naples and with distinction in Anaesthesiology and Intensive Care from the University of Pisa; additional studies in Rheumatology, Dermatology, Proctology, Oncology, Surgery, Drugs Abuse, Emergency Treatment, Disaster Action, Hospital Organization, Medical Teaching Methodology and Computer and Audio-Visual Training for the Medical Profession
• President of European Medical Association (EMA, emanet.org), Honorary President of EPMA and its founding member, President of European Depression Association (EDA, europeandepressionday.eu) and board member of many other medical institutions
|
 Dr. Kurt Krapfenbauer
• Ph.D. and master’s degree in chemistry (both degrees from University of Vienna)
• Inventor of more than 9 international patents, leading to the Roche Inventory Award 2005
• Author of more than 55 scientific publications on Biochemical Research
• Experience as laboratory head at Hoffman LaRoche, and as head of Biomarker Research at the Novartis Institutes for Biomedical Research in Basel, Switzerland. His responsibilities have included Research & Development, Manufacturing Operations, Technical Operations and Quality Assurance.
• Postgraduate study with a degree as a “Qualified Person”
• Extensive experience as senior scientist in Biomarker research including development and validation of Biomarker essays
• Founding member of EPMA with following functions:
2008-2021: Vice President for European Affairs
since 2021: Vice President for International Affairs
|
 Dr. Marko Kapalla
• Specialized Clinical Biochemist, Natural scientist, Quality manager (ISO 15 189)
• Ph.D. in Normal and Pathological Physiology
• EPMA vice-president for European Affairs (since 2021) and its founding member
• National representative of EPMA in Slovakia
• Associate editor of the EPMA Journal, SpringerNature
• CEO of “PPPM Centre, s.r.o.” (pppmc.sk)
|
 Dr. Jiří Polívka
• Department of Histology and Embryology, research at the University Hospital Plzeň and at the Biomedical Center, Faculty of Medicine in Plzeň, Charles University
• Doctoral study (at the Faculty of Medicine in Plzeň, Charles University) in General Medicine: Anatomy, Histology and Embryology
• Fields of activity: oncology, neuro-oncology, preventive oncology, neurosciences and clinical chemistry
• Secretary General of EPMA (since 2021)
• Editorial board member of the EPMA Journal and of the book series “Advances in Predictive, Preventive and Personalised Medicine”, SpringerNature
• (Co-)Author of 47 publications, having more than 1250 citations. H index 19.
• Awards:
2012 The Josef Hlavka Prize
2014 Prize of the Plzeň Region
|
 Michel Joseph Girard
• Graduate in business administration, entrepreneur
|
 Thomas Scherenhorst
• Graduate in business administration, tax consultant
|
 Alessandra Malatesta, LL.B. (Florence/Cologne)
• Lawyer, consultant to “3PMedicon GmbH” and EPMA
|
 Dr. jur. Pavel Labuda, LL.M. (Cologne/Paris I)
• CEO of “3PMedicon GmbH”
• Lawyer, EPMA Director responsible for Legal Affairs (since 2017)
|
